After A Decade Of US Biosimilars, ‘The Challenges Are Becoming More Clear’

Biosimilars Council Chief Craig Burton Discusses Progress And The Road Ahead

 
• By Dave Wallace
  
Biosimilars are entering their second decade on the US market (Shutterstock)

More from Interviews

More from Policy & Regulation